(lp0
S'Aviragen Therapeutics Announces Review of Strategic Alternatives and Provides ... GlobeNewswire  - Apr 4, 2017 ATLANTA, April 04, 2017  -- Aviragen Therapeutics, Inc. , a company focused on the discovery and development of the next generation of direct-acting antivirals to treat infections that have limited therapeutic options,&nbsp;...Aviragen to explore strategic alternatives - Seeking AlphaAviragen Cutting Jobs, Exploring Strategic Alternatives - Genetic Engineering & Biotechnology News'
p1
aS"Aviragen Therapeutics Inc : What's Next? Insider Financial - Feb 16, 2017 Aviragen Therapeutics Inc  is not having a good week. The company just put out data from a phase 2 study of its lead development asset, and has taken a close to 40% hit on the news."
p2
aS'0.58 MarketWatch - May 4, 2016 Aviragen Therapeutics Inc. Aviragen Therapeutics, Inc. engages in the discovery and development of direct-acting antivirals to treat infections.'
p3
aS'Aviragen Therapeutics to Host Conference Call to Report First Quarter Fiscal ... GlobeNewswire  - Oct 27, 2016 ATLANTA, Oct. 27, 2016  -- Aviragen Therapeutics, Inc. , a pharmaceutical company that is developing the next generation of antivirals, today announced that management will host a conference call on Thursday,&nbsp;...'
p4
aS'Aviragen Therapeutics slammed again by its second trial failure in days, this ... Endpoints News - Feb 13, 2017 In back-to-back setbacks, Aviragen Therapeutics $AVIR says that its lead drug vapendavir flunked a Phase IIb in moderate to severe asthmatics with a rhinovirus infection.'
p5
aS"Aviragen Therapeutics'  CEO Joseph Patti on Q2 2017 Results - Earnings ... Seeking Alpha - Feb 3, 2017 Good day, ladies and gentlemen, and welcome to the Aviragen Therapeutics, Inc. Second Quarter 2017 Financial Results Conference Call.Aviragen Hits 52-Week Low on Drug Failure  - Investopedia"
p6
aS'Biota Pharmaceuticals Is Now Aviragen Therapeutics Seeking Alpha - Apr 27, 2016 Subsequent to our last update on Aviragen Therapeutics, the company has been busy attending and presenting at industry conferences.'
p7
aS'Aviragen Therapeutics Announces Inducement Grant for New Employees GlobeNewswire  - Sep 6, 2016 ATLANTA, Sept. 06, 2016  -- Aviragen Therapeutics, Inc.  , a pharmaceutical company that is developing the next generation of antivirals, announced today that the Company has&nbsp;...'
p8
aS"Aviragen Therapeutics'  CEO Dr. Joseph Patti on Q4 2016 Results ... Seeking Alpha - Sep 14, 2016 I would like to welcome you to the Aviragen Therapeutics conference call and webcast to review the Company's fourth quarter and fiscal yearend 2016 earnings results to provide an update on recent pipeline and corporate developments."
p9
aS'Spotting the Levels for Aviragen Therapeutics Inc  Rives Journal - 19 hours ago Taking a peek at some moving average levels on shares of Aviragen Therapeutics Inc , the 200-day is at 1.22, the 50-day is 0.71, and the 7-day is sitting at 0.59.'
p10
a.